Tarek Sousou is an Oncology physician affiliated with University of Rochester. OpenAlex indexes 10 publications with 388 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5008 Brittonfield Pkwy
East Syracuse, NY 13057
Telephone
315-472-7504Registry record last updated 3 Aug 2018.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20252 payments
- ASD Specialty Healthcare, LLCProgram year20251 payment
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
44.7%PD-1 inhibitor20.1%Pembrolizumab55%Nivolumab45%Part B, office-administered≥46 patientsNucleoside Metabolic Inhibitor6.5%Azacitidine91%Fluorouracil7%Gemcitabine hydrochloride2%Part B, office-administered≥37 patients+ 11 more classes in this area
Blood & clotting
30.6%Iron, parenteral preparations19.8%Ferric carboxymaltose100%Part B, office-administered≥44 patientsErythropoiesis-stimulating Agent10.8%Darbepoetin alfa97%Epoetin alfa3%Part B, office-administered≥39 patients+ 1 more class in this area
Metabolism & gastrointestinal
11.3%Substance P/Neurokinin-1 Receptor Antagonist8.4%Aprepitant100%Part B, office-administered≥65 patientsSerotonin-3 Receptor Antagonist1.5%Palonosetron hcl82%Granisetron hydrochloride15%Ondansetron hydrochloride4%Part B, office-administered≥103 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer
Thrombosis and Haemostasis
2011 - High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients
Journal of Thrombosis and Haemostasis
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Geoffrey Weinberg, MD
University of Rochester
David Bushinsky, MD
University of Rochester
Mark Taubman, MD
University of Rochester
Richard Sterns, MD
University of Rochester
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”